{"id":309851,"date":"2019-12-13T21:30:01","date_gmt":"2019-12-14T05:30:01","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-eagle-pharma-on-go-to-launch-alimta-alternative-fda-clears-boston-scientific-single-use-duodenoscope\/"},"modified":"2019-12-13T21:30:25","modified_gmt":"2019-12-14T05:30:25","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-eagle-pharma-%e5%8d%b3%e5%b0%86%e6%8e%a8%e5%87%ba-alimta-%e6%9b%bf%e4%bb%a3%e5%93%81-fda%e6%89%b9%e5%87%86-boston-scientific-%e4%b8%80%e6%ac%a1","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/12\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-eagle-pharma-%e5%8d%b3%e5%b0%86%e6%8e%a8%e5%87%ba-alimta-%e6%9b%bf%e4%bb%a3%e5%93%81-fda%e6%89%b9%e5%87%86-boston-scientific-%e4%b8%80%e6%ac%a1\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014Eagle Pharma\u5373\u5c06\u63a8\u51faAlimta\u66ff\u4ee3\u54c1\uff0cFDA\u6279\u51c6Boston Scientific\u4e00\u6b21\u6027\u5341\u4e8c\u6307\u80a0\u955c"},"content":{"rendered":"

Eagle Pharma\u5c06\u4e8e2022\u5e74\u521d\u63a8\u51fa\u80bf\u7624\u836f\u7231\u5b81\u8fbe\u66ff\u4ee3\u54c1<\/h2>\n

Eagle Pharmaceuticals\uff08EGRX + 2.5%\uff09<\/a>\u5df2\u89e3\u51b3\u4e86\u793c\u6765\uff08LLY-0.3%\uff09\u4e0e\u540e\u8005\u7684\u5316\u5b66\u836f\u7269\u7231\u5b81\u8fbe\uff08Alimta\uff0c\u6ce8\u5c04\u7528\u57f9\u7f8e\u66f2\u585e\uff09\u6709\u5173\u7684\u6240\u6709\u4e13\u5229\u95ee\u9898\u3002<\/p>\n

\u6839\u636e\u548c\u89e3\u534f\u8bae\u7684\u6761\u6b3e\uff0cEagle\u6700\u521d\u5c06\u901a\u8fc7\u5176\u66ff\u4ee3\u4ea7\u54c1Pemfexy\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\uff0c\u5e76\u4e8e2022\u5e742\u67081\u65e5\u4e0a\u5e02\uff0c\u7136\u540e\u57282022\u5e744\u67081\u65e5\u5168\u9762\u6295\u5165\u5546\u4e1a\u8fd0\u8425\u3002<\/p>\n

Monopar Therapeutics\u7f29\u5c0fIPO\u89c4\u6a21<\/h2>\n

Monopar Therapeutics\uff08MNPR\uff09<\/a>\u5df2\u63d0\u4ea4\u521d\u6b65\u62db\u80a1\u8bf4\u660e\u4e66\uff0c\u4ee5\u6bcf\u80a18-10\u7f8e\u5143\u7684\u4ef7\u683c\u53d1\u884c\u7ea6110\u4e07\u80a1\u666e\u901a\u80a1\u3002<\/p>\n

9\u6708\uff0c\u8be5\u516c\u53f8\u7533\u8bf7\u4ee5\u76f8\u540c\u7684\u4ef7\u683c\u53d1\u884c\u7ea6440\u4e07\u80a1\u80a1\u7968\u3002<\/p>\n

FDA\u6279\u51c6Boston Scientific\u4e00\u6b21\u6027\u5341\u4e8c\u6307\u80a0\u955c<\/h2>\n

FDA\u6388\u4e88\u6279\u51c6Boston Scientific\u4e00\u6b21\u6027\u5341\u4e8c\u6307\u80a0\u955cEXALT\uff0c\u7528\u4e8e\u5185\u7aa5\u955c\u9006\u884c\u80f0\u80c6\u7ba1\u9020\u5f71\u672f\uff08\u65e8\u5728\u8bca\u65ad\u809d\u810f\uff0c\u80c6\u56ca\uff0c\u80c6\u7ba1\u548c\u80f0\u817a\u4e2d\u7684\u95ee\u9898\u3002<\/p>\n

\u8be5\u516c\u53f8\u8868\u793a\uff0c\u8fd9\u662f\u7f8e\u56fd\u7b2c\u4e00\u53f0\u8fd9\u79cd\u4e00\u6b21\u6027\u4f7f\u7528\u7684\u8bbe\u5907\uff08\u5176\u4ed6\u5341\u4e8c\u6307\u80a0\u955c\u662f\u53ef\u91cd\u590d\u4f7f\u7528\u7684\uff0c\u5982\u679c\u672a\u5f7b\u5e95\u6e05\u6d01\uff0c\u5219\u5b58\u5728\u611f\u67d3\u98ce\u9669\uff09\u3002<\/p>\n

Tenet \u51fa\u552e\u533b\u9662\u7b49\u8bbe\u65bd<\/h2>\n

Tenet Healthcare\uff08THC + 0.6%\uff09<\/a>\u540c\u610f\u4ee5\u672a\u516c\u5f00\u7684\u4ef7\u683c\u51fa\u552e\u4e24\u5bb6\u533b\u9662\u53ca\u5176\u76f8\u5173\u7684\u533b\u5e08\u8bca\u6240\u548c\u516d\u4e2a\u6025\u8bca\u4e2d\u5fc3\u3002\u8be5\u4ea4\u6613\u5e94\u57282020\u5e74\u5b8c\u6210\u3002<\/p>\n

\u6b27\u6d32\u54a8\u8be2\u6279\u51c6\u6269\u5927\u8f89\u745eVyndaqel \u6cbb\u7597\u8303\u56f4<\/h2>\n

\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\u7684\u54a8\u8be2\u5c0f\u7ec4CHMP\u901a\u8fc7\u4e86\u4e00\u9879\u79ef\u6781\u7684\u610f\u89c1\uff0c\u5efa\u8bae\u6279\u51c6\u8f89\u745e\u516c\u53f8\uff08NYSE\uff1aPFE\uff09<\/a>\u7684Vyndaqel\uff08\u4ed6\u6cd5\u7c73\u5730\uff09\u7528\u4e8e\u6bcf\u65e5\u4e00\u6b21\u6cbb\u7597\u60a3\u6709\u5fc3\u808c\u75c5\u7684\u6210\u4eba\u7684\u91ce\u751f\u578b\u6216\u9057\u4f20\u6027\u7532\u72b6\u817a\u7d20\u8f6c\u57fa\u56e0\u6dc0\u7c89\u6837\u53d8\u6027\u75c5\u3002<\/p>\n

\u76ee\u524d\uff0c\u6b27\u6d32\u5df2\u7ecf\u6279\u51c6\u4e86\u53e6\u4e00\u79cd\u5f62\u5f0f\u7684\u8fd0\u7532\u72b6\u817a\u7d20\u86cb\u767d\u7a33\u5b9a\u5242\u7528\u4e8e\u60a3\u67091\u671f\u75c7\u72b6\u6027\u591a\u53d1\u6027\u795e\u7ecf\u75c5\uff08ATTR-PN\uff09\u7684\u6210\u5e74\u60a3\u8005\u7684\u8fd0\u7532\u72b6\u817a\u7d20\u86cb\u767d\u6dc0\u7c89\u6837\u53d8\u6027\u75c5\uff0c\u4ee5\u5ef6\u8fdf\u5468\u56f4\u795e\u7ecf\u529f\u80fd\u969c\u788d\u3002<\/p>\n

\u6b27\u76df\u59d4\u5458\u4f1a\u7684\u6700\u7ec8\u51b3\u5b9a\u901a\u5e38\u9700\u898160\u5929\u5de6\u53f3\uff0c\u4f46\u6700\u8fd1\u8d8b\u5411\u4e8e\u63a5\u8fd130\u5929\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Eagle Pharmaceuticals (EGRX +2.5%) has settled all patent issues with Eli Lilly (LLY -0.3%) related to the latter’s chemo drug Alimta (pemetrexed for injection). The FDA grants 510(k) clearance to Boston Scientific’s (BSX +0.7%) EXALT Model D, a single-use duodenoscope (a hollow lighted tube for inspecting the small intestine) for use in endoscopic retrograde cholangiopancreatography procedures (aimed at diagnosing issues in the liver, gallbladder, bile ducts and pancreas).<\/p>\n","protected":false},"author":9,"featured_media":309839,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-309851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/309851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=309851"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/309851\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/309839"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=309851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=309851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=309851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}